Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (281-290 of 664) with videos related to

Pageof 67
Sort By:
Thrombosis Research|December 8, 2020
Prevalence of definite antiphospholipid syndrome in carriers of the JAK2<sup>V617F</sup> mutationSnjezana Janjetovic, Lennart Beckmann, Katharina Holstein, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 13, 2014
A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancerCarsten Bokemeyer, Alexander Stein, Karsten Ridwelski, et al.
Journal of Geriatric Oncology|November 11, 2016
Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study)Matti Aapro, Carsten Bokemeyer, Heinz Ludwig, et al.
Biomed Research International|September 13, 2014
Aaptamines from the marine sponge Aaptos sp. display anticancer activities in human cancer cell lines and modulate AP-1-, NF-κB-, and p53-dependent transcriptional activity in mouse JB6 Cl41 cellsSergey A Dyshlovoy, Sergey N Fedorov, Larisa K Shubina, et al.
Pathology Oncology Research : POR|September 9, 2015
Loss of H2Bub1 Expression is Linked to Poor Prognosis in Nodal Negative Colorectal CancersNathaniel Melling, Norbert Grimm, Ronald Simon, et al.
Tobacco Use Insights|October 13, 2025
Formerly Smoking and Currently Smoking Cancer Survivors' View on Smoking Cessation - A Qualitative StudyFrederike Bokemeyer, Johanna Springorum, Lisa Lebherz, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Surgical Site Cytology to Diagnose Spinal LesionsLeon-Gordian Koepke, Annika Heuer, Martin Stangenberg, et al.
Journal of Cancer Research and Clinical Oncology|September 21, 2018
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study GroupMartin Fenner, Christoph Oing, Annette Dieing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Role of P53 and MDM2 in treatment response of human germ cell tumorsAnne-Marie F Kersemaekers, Frank Mayer, Michel Molier, et al.
Onkologie|March 15, 2013
Management of cytotoxic extravasation - ASORS expert opinion for diagnosis, prevention and treatmentMaike de Wit, Petra Ortner, Hans-Peter Lipp, et al.
Pageof 67

Showing results (281-290 of 664) with videos related to

Sort By:
Pageof 67
Thrombosis Research|December 8, 2020
Prevalence of definite antiphospholipid syndrome in carriers of the JAK2<sup>V617F</sup> mutationSnjezana Janjetovic, Lennart Beckmann, Katharina Holstein, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 13, 2014
A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancerCarsten Bokemeyer, Alexander Stein, Karsten Ridwelski, et al.
Journal of Geriatric Oncology|November 11, 2016
Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study)Matti Aapro, Carsten Bokemeyer, Heinz Ludwig, et al.
Biomed Research International|September 13, 2014
Aaptamines from the marine sponge Aaptos sp. display anticancer activities in human cancer cell lines and modulate AP-1-, NF-κB-, and p53-dependent transcriptional activity in mouse JB6 Cl41 cellsSergey A Dyshlovoy, Sergey N Fedorov, Larisa K Shubina, et al.
Pathology Oncology Research : POR|September 9, 2015
Loss of H2Bub1 Expression is Linked to Poor Prognosis in Nodal Negative Colorectal CancersNathaniel Melling, Norbert Grimm, Ronald Simon, et al.
Tobacco Use Insights|October 13, 2025
Formerly Smoking and Currently Smoking Cancer Survivors' View on Smoking Cessation - A Qualitative StudyFrederike Bokemeyer, Johanna Springorum, Lisa Lebherz, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Surgical Site Cytology to Diagnose Spinal LesionsLeon-Gordian Koepke, Annika Heuer, Martin Stangenberg, et al.
Journal of Cancer Research and Clinical Oncology|September 21, 2018
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study GroupMartin Fenner, Christoph Oing, Annette Dieing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Role of P53 and MDM2 in treatment response of human germ cell tumorsAnne-Marie F Kersemaekers, Frank Mayer, Michel Molier, et al.
Onkologie|March 15, 2013
Management of cytotoxic extravasation - ASORS expert opinion for diagnosis, prevention and treatmentMaike de Wit, Petra Ortner, Hans-Peter Lipp, et al.
Pageof 67